Mortality in solid organ transplant recipients hospitalized for COVID-19
- PMID: 34738312
- PMCID: PMC8652626
- DOI: 10.1111/ajt.16885
Mortality in solid organ transplant recipients hospitalized for COVID-19
Abstract
Kalil and Florescu discuss the growing evidence related to survival outcomes of solid organ transplant patients who are hospitalized due to COVID-19 and place this evidence within the context of other post-transplant infections. See Heldman et al. (
Keywords: clinical research/practice; infection and infectious agents; infection and infectious agents - viral; infectious disease.
Comment in
-
Apples to apples: The challenges of studying COVID-19 mortality in solid organ transplant recipients.Am J Transplant. 2022 Jul;22(7):1929-1930. doi: 10.1111/ajt.16989. Epub 2022 Feb 15. Am J Transplant. 2022. PMID: 35114731 Free PMC article. No abstract available.
Comment on
-
Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic.Am J Transplant. 2022 Jan;22(1):279-288. doi: 10.1111/ajt.16840. Epub 2021 Oct 7. Am J Transplant. 2022. PMID: 34514710 Free PMC article.
References
-
- Kalil AC, Sandkovsky U, Florescu DF. Severe infections in critically ill solid organ transplant recipients. Clin Microbiol Infect. 2018;24(12):1257–1263. - PubMed
-
- Florescu DF, Qiu F, Schmidt CM, Kalil AC. A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant. Clin Infect Dis. 2014;58(6):785–803. - PubMed
-
- Kalil AC, Florescu MC, Grant W, et al. Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysis. Expert Rev Anti Infect Ther. 2014;12(7):881–896. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
